Back to feed
FULCFULCRUM THERAPEUTICS INC
CIK 0001680581 · no recent filings · 0 insider transactions
Buy volume
$0
0 buy transactions
Sell volume
$0
0 sell transactions
Net flow
+$0
Net buying
Total flow
$0
0 priced transactions
Disclosure radarcross-source convergence
Divergent4/5 sources
26/100
Recent disclosures · timeline
- Form 1442d ago
Proposed sale of 18,000 sh ($65.0K) · discretionary
- 8-K5.073d ago
Submission of matters to a shareholder vote
- Schedule 13G3d ago
5%+ stake · passive (13G)
- Schedule 13G
Price · FULC
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
Material events · 8-K
FULC corporate events · live SEC data- 5.073d ago
Submission of matters to a shareholder vote
Form 8-K — items reported: 5.07 Submission of matters to a shareholder vote.
Item 5.07 · Submission of matters to a shareholder voteView 8-K on EDGAR ↗
Institutional holders · 13F
Q1 2026 vs Q4 2025 · live SEC data9 funds hold$123.69M reported valueNet accumulating(7 adding · 2 reducing)
| Fund | Shares | Value | % of portfolio | QoQ |
|---|---|---|---|---|
| BlackRock Inc | 5,390,593 | $41.35M | 0.0% | Add+26% |
| Vanguard Group Inc | 3,559,552 | $40.26M | 0.0% | Add+19% |
| Point72 Asset Management, L.P. Steve Cohen | 2,074,855 | $15.91M | 0.2% |
5%+ stakes · Schedule 13D/G
Proposed sales · Form 144
selling intent · live SEC data1 notice$65.0K proposed to sell0/1 under a 10b5-1 plan
| Filed | Filer | Shares | Est. value | Approx. sale | Source of shares | Plan |
|---|---|---|---|---|---|---|
| 2d ago | ALAN EZEKOWITZ Director | 18,000 | $65.0K | Jun 26, 2026 | Restricted Stock Units | Discretionary |
Recent insider transactions
No insider transactions recorded for FULC.